On average, 7 out of 10 retail investors suffer losses when trading turbo certificates. Turbo certificates are highly risky products and are not suited for long-term investment strategies.
6.076 - 6.100 of 94.502
- Product
- Maturity
- Leverage (Omega)
- Sell
- Buy
- Moderna Call 255,00 19 Jan 2029
- Goldman Sachs
- 19.01.29
- 1,62x
- Analysis
- SNDK UW Put 75,00 15 Jan 2027
- Goldman Sachs
- 15.01.27
- 2,28x
- Analysis
- Spotify Technology Call 670,00 17 Mar 2028
- Goldman Sachs
- 17.03.28
- 2,65x
- Analysis
- SpaceX Call 220,00 19 Jan 2029
- Goldman Sachs
- 19.01.29
- 2,15x
- Analysis
- Caterpillar Inc Put 700,00 15 Sep 2028
- Goldman Sachs
- 15.09.28
- 1,12x
- Analysis
- Coinbase Put 220,00 21 Jan 2028
- Goldman Sachs
- 21.01.28
- 0,53x
- Analysis
- Regeneron Pharmaceuticals Call 980,00 19 Jan 2029
- Goldman Sachs
- 19.01.29
- 2,31x
- Analysis
- Regeneron Pharmaceuticals Call 1.010,00 16 Jun 2028
- Goldman Sachs
- 16.06.28
- 2,70x
- Analysis
- Expedia Call 325,00 19 Jan 2029
- Goldman Sachs
- 19.01.29
- 2,06x
- Analysis
- Regeneron Pharmaceuticals Call 1.030,00 15 Sep 2028
- Goldman Sachs
- 15.09.28
- 2,57x
- Analysis
- Coinbase Put 80,00 21 Jan 2028
- Goldman Sachs
- 21.01.28
- 1,34x
- Analysis
- Comfort Systems USA Call 1.140,00 19 Jan 2029
- Goldman Sachs
- 19.01.29
- 1,67x
- Analysis
- Mercadolibre Call 1.480,00 17 Mar 2028
- Goldman Sachs
- 17.03.28
- 2,57x
- Analysis
- Alphabet - Class A Put 150,00 16 Mar 2029
- Goldman Sachs
- 16.03.29
- 2,86x
- Analysis
- Caterpillar Inc Put 700,00 16 Jun 2028
- Goldman Sachs
- 16.06.28
- 1,22x
- Analysis
- Coinbase Put 80,00 15 Sep 2028
- Goldman Sachs
- 15.09.28
- 0,97x
- Analysis
- Robinhood Call 76,00 15 Dec 2028
- Goldman Sachs
- 15.12.28
- 1,70x
- Analysis
- NXP Semiconductors NV Call 295,00 19 Jan 2029
- Goldman Sachs
- 19.01.29
- 2,14x
- Analysis
- Illumina, Inc. Call 225,00 19 Jan 2029
- Goldman Sachs
- 19.01.29
- 1,73x
- Analysis
- Regeneron Pharmaceuticals Call 960,00 15 Dec 2028
- Goldman Sachs
- 15.12.28
- 2,34x
- Analysis
- NXP Semiconductors NV Call 290,00 15 Dec 2028
- Goldman Sachs
- 15.12.28
- 2,19x
- Analysis
- Gilead Sciences Call 195,00 17 Dec 2027
- Goldman Sachs
- 17.12.27
- 4,04x
- Analysis
- Regeneron Pharmaceuticals Call 1.010,00 15 Dec 2028
- Goldman Sachs
- 15.12.28
- 2,38x
- Analysis
- Regeneron Pharmaceuticals Call 990,00 17 Dec 2027
- Goldman Sachs
- 17.12.27
- 3,35x
- Analysis
- Illumina, Inc. Call 225,00 17 Dec 2027
- Goldman Sachs
- 17.12.27
- 2,34x
- Analysis